LivaNova (NASDAQ:LIVN) Stock Price Crosses Below Fifty Day Moving Average – Here’s Why

LivaNova PLC (NASDAQ:LIVN) passed below its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $78.57 and traded as low as $77.39. LivaNova shares last traded at $78.14, with a volume of 387,101 shares traded.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on LIVN. Stifel Nicolaus set a $85.00 price target on LivaNova in a report on Wednesday, August 5th. Zacks Research downgraded LivaNova from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 19th. Weiss Ratings raised LivaNova from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, August 18th. Barclays raised LivaNova to a “strong-buy” rating in a research note on Wednesday, October 7th. Finally, Mizuho increased their target price on LivaNova from $90.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $87.75.

LivaNova Stock Down 1.6%

The stock has a market cap of $4.32 billion, a price-to-earnings ratio of 22.20 and a beta of 0.87. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.45. The firm’s 50-day simple moving average is $78.55 and its two-hundred day simple moving average is $75.93.

LivaNova (NASDAQ:LIVN) last announced its earnings results on Thursday, August 6th. The company reported $1.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.09 by $0.17. LivaNova had a net margin of 12.82% and a return on equity of 16.35%. The company had revenue of $390.59 million for the quarter, compared to analyst estimates of $380.50 million. During the same period in the prior year, the business earned $1.05 earnings per share. LivaNova’s quarterly revenue was up 10.8% on a year-over-year basis. On average, sell-side analysts expect that LivaNova PLC will post 3.78 EPS for the current fiscal year.

Insider Activity at LivaNova

In other LivaNova news, Director Francesco Bianchi sold 3,500 shares of the stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $78.01, for a total value of $273,035.00. Following the transaction, the director directly owned 4,434 shares in the company, valued at approximately $345,896.34. This trade represents a 44.11% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Brooke Story sold 2,300 shares of the stock in a transaction on Friday, September 4th. The shares were sold at an average price of $81.42, for a total value of $187,266.00. Following the completion of the transaction, the director owned 7,488 shares in the company, valued at $609,672.96. The trade was a 23.50% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 7,450 shares of company stock valued at $591,839 in the last 90 days. 0.35% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On LivaNova

A number of institutional investors and hedge funds have recently made changes to their positions in LIVN. Allworth Financial LP grew its position in shares of LivaNova by 93.5% during the 2nd quarter. Allworth Financial LP now owns 298 shares of the company’s stock worth $25,000 after buying an additional 144 shares during the period. Farther Finance Advisors LLC raised its stake in shares of LivaNova by 59.7% during the third quarter. Farther Finance Advisors LLC now owns 452 shares of the company’s stock worth $35,000 after buying an additional 169 shares during the last quarter. State of Michigan Retirement System raised its stake in shares of LivaNova by 1.5% during the first quarter. State of Michigan Retirement System now owns 13,111 shares of the company’s stock worth $833,000 after buying an additional 200 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of LivaNova by 12.5% during the third quarter. GAMMA Investing LLC now owns 2,068 shares of the company’s stock worth $158,000 after buying an additional 230 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund lifted its holdings in LivaNova by 2.7% in the first quarter. Oregon Public Employees Retirement Fund now owns 11,250 shares of the company’s stock valued at $715,000 after buying an additional 300 shares during the period. Institutional investors own 97.64% of the company’s stock.

LivaNova Company Profile

LivaNova PLC (NASDAQ: LIVN) is a medical technology company that develops and manufactures devices and therapies for patients with neurological and cardiovascular conditions. Its products are used by hospitals, physicians and other healthcare providers in markets around the world.

The company’s Neuromodulation business is best known for VNS Therapy, which uses an implanted device to deliver electrical stimulation to the vagus nerve. The therapy is used primarily for drug-resistant epilepsy and treatment-resistant depression, subject to applicable regulatory approvals.